immunoglobulinum humanum varicellae 25 U.I. corresp. proteina plasmatis humani 50 mg ex illo immunoglobulinum humanum normale (IgG1: ca. 62 %, IgG2: ca. 33 %, IgG3: ca. 3 %, IgG4: ca. 2 %) 96 %, immunoglobulinum humanum A max. 2 mg, glycinum, aqua q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Lösung zur intravenösen Injektion
Active Agent
Dose
Immunoglobulinum Humanum Varicellae 25 u.I. Corresp. Proteina Plasmatis Humani 50 mg ex illo Immunoglobulinum Humanum Normale (Igg1: ca. 62 %, Igg2: ca. 33 %, Igg3: ca. 3 %, Igg4: ca. 2 %)
96 %/ml
BAG: Active Agent
Dose
Immunoglobulinum Humanum Anti-Varicellae
1250 UI
Inactive agents
Dose
Glycin
Immunoglobulinum Humanum A
2 mg/ml
Source
Data was imported : 08.06.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
